JP2025503592A5 - - Google Patents
Info
- Publication number
- JP2025503592A5 JP2025503592A5 JP2024540747A JP2024540747A JP2025503592A5 JP 2025503592 A5 JP2025503592 A5 JP 2025503592A5 JP 2024540747 A JP2024540747 A JP 2024540747A JP 2024540747 A JP2024540747 A JP 2024540747A JP 2025503592 A5 JP2025503592 A5 JP 2025503592A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutically acceptable
- compound according
- independently
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263296705P | 2022-01-05 | 2022-01-05 | |
| US63/296,705 | 2022-01-05 | ||
| US202263435654P | 2022-12-28 | 2022-12-28 | |
| US63/435,654 | 2022-12-28 | ||
| PCT/US2023/060039 WO2023133375A1 (en) | 2022-01-05 | 2023-01-03 | Macrocyclic compounds and use as kinase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503592A JP2025503592A (ja) | 2025-02-04 |
| JP2025503592A5 true JP2025503592A5 (https=) | 2026-01-14 |
Family
ID=87074235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024540747A Pending JP2025503592A (ja) | 2022-01-05 | 2023-01-03 | 大環状化合物およびキナーゼ阻害剤としての使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250074920A1 (https=) |
| EP (1) | EP4460498A4 (https=) |
| JP (1) | JP2025503592A (https=) |
| KR (1) | KR20240131416A (https=) |
| AU (1) | AU2023204770A1 (https=) |
| CA (1) | CA3246487A1 (https=) |
| IL (1) | IL314070A (https=) |
| MX (1) | MX2024008413A (https=) |
| TW (1) | TW202334168A (https=) |
| WO (1) | WO2023133375A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024266587A1 (en) * | 2023-05-02 | 2025-09-11 | Blossomhill Therapeutics, Inc. | Egfr inhibitors for treating disease |
| WO2025212729A1 (en) * | 2024-04-03 | 2025-10-09 | Blossomhill Therapeutics, Inc. | Macrocyclic compounds and their use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ME03376B (me) * | 2010-05-20 | 2020-01-20 | Array Biopharma Inc | Makrociklička jedinjenja kао inhibiтori trk kinaze |
| US20160031888A1 (en) * | 2013-03-13 | 2016-02-04 | Boston Biomedical, Inc. | 3-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancer |
| ES2933350T3 (es) * | 2014-01-24 | 2023-02-06 | Turning Point Therapeutics Inc | Macrociclos de diarilo como moduladores de proteína quinasas |
| TWI707852B (zh) * | 2015-09-02 | 2020-10-21 | 美商林伯士拉克許米公司 | Tyk2 抑制劑及其用途 |
| EP4178958A4 (en) * | 2020-07-10 | 2024-12-11 | Blossomhill Therapeutics, Inc. | MACROCYCLES AND THEIR USE |
-
2023
- 2023-01-03 AU AU2023204770A patent/AU2023204770A1/en active Pending
- 2023-01-03 WO PCT/US2023/060039 patent/WO2023133375A1/en not_active Ceased
- 2023-01-03 MX MX2024008413A patent/MX2024008413A/es unknown
- 2023-01-03 KR KR1020247025807A patent/KR20240131416A/ko active Pending
- 2023-01-03 CA CA3246487A patent/CA3246487A1/en active Pending
- 2023-01-03 JP JP2024540747A patent/JP2025503592A/ja active Pending
- 2023-01-03 EP EP23737695.9A patent/EP4460498A4/en active Pending
- 2023-01-03 US US18/725,951 patent/US20250074920A1/en active Pending
- 2023-01-03 IL IL314070A patent/IL314070A/en unknown
- 2023-01-05 TW TW112100378A patent/TW202334168A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025503592A5 (https=) | ||
| AU2017248551B2 (en) | Multicyclic compounds and methods of use thereof | |
| JP2025525411A (ja) | 疾患を治療するための縮合環ｋｒａｓ阻害剤 | |
| TWI641609B (zh) | 一種ｊａｋ激酶抑制劑的硫酸氫鹽及其製備方法 | |
| JP2018070614A5 (https=) | ||
| JP2020528062A (ja) | ピペラジンヘテロアリール誘導体、その製造方法、およびその医薬での使用 | |
| JP2011511802A (ja) | Ａｂｃａ−１を上昇させる化合物およびかかる化合物の使用方法 | |
| JP2007509055A5 (https=) | ||
| JP2010532381A5 (https=) | ||
| JP2010510215A5 (https=) | ||
| JP2018513832A5 (https=) | ||
| RU2000131220A (ru) | Новые аналоги жирных кислот для лечения первичного и вторичного рестеноза | |
| EP2512477A1 (en) | Hcv combination therapy | |
| JP2018522867A5 (https=) | ||
| JP2004531563A5 (https=) | ||
| JP2013512951A (ja) | 新規オキサジアゾール化合物 | |
| JP2020503341A5 (https=) | ||
| ES2702192T3 (es) | Compuestos de 6,7-dihidropirazolo[1,5-a]pirazin-4(5H)-ona y su uso como moduladores alostéricos negativos de receptores de mGlu2 | |
| WO1998029115A1 (en) | Transition-metal nitrosyl compounds as smooth muscle relaxants | |
| JP2002532503A5 (https=) | ||
| CN108290880B (zh) | 内酰胺类化合物衍生物及其应用 | |
| JP2004525972A5 (https=) | ||
| JP2024510502A5 (https=) | ||
| KR920016418A (ko) | Nmda 길항제 | |
| JP6268656B2 (ja) | ヒト免疫不全ウイルス複製の阻害剤 |